Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06958419
What this trial is testing

Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)

Who this might be right for
Immune Checkpoint TherapyRadiotherapyMetastatic Colorectal Cancer (CRC)
Sixth Affiliated Hospital, Sun Yat-sen University 286
Not applicableUnknownNCT05493956
What this trial is testing

A Randomised Study of Consolidation CTRT Versus Observation After First Line Chemotherapy in Advanced Gallbladder Cancer

Who this might be right for
Gallbladder Cancer Unresectable
Sanjay Gandhi Postgraduate Institute of Medical Sciences 120
Testing effectiveness (Phase 2)Study completedNCT02665039
What this trial is testing

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 62
Testing effectiveness (Phase 2)Ended earlyNCT03301454
What this trial is testing

Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer, Squamous Cell
Centre Oscar Lambret 15
Not applicableUnknownNCT05168254
What this trial is testing

Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 50
Testing effectiveness (Phase 2)Study completedNCT06010303
What this trial is testing

Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerEsophageal Squamous Cell CarcinomaEsophageal Squamous Cell Carcinoma by AJCC V8 Stage
BeiGene 118
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712094
What this trial is testing

AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Cancer
Tianjin Medical University Cancer Institute and Hospital 56
Testing effectiveness (Phase 2)Study completedNCT00627042
What this trial is testing

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Who this might be right for
Hepatocellular Carcinoma
Eli Lilly and Company 42
Large-scale testing (Phase 3)Study completedNCT01005680
What this trial is testing

A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 256
Large-scale testing (Phase 3)Looking for participantsNCT07050043
What this trial is testing

Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)First Line TherapyLocally Advanced/Metastatic NSCLC
Dr Arvindran A/L Alaga 123
Post-approval studies (Phase 4)Study completedNCT00466258
What this trial is testing

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsDiffuse Large B Cell Lymphoma
PETHEMA Foundation 50
Not applicableStudy completedNCT01811108
What this trial is testing

Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Oncology Research Group 670
Not applicableActive Not RecruitingNCT05415358
What this trial is testing

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Who this might be right for
Lung Cancer, Nonsmall Cell
Wake Forest University Health Sciences 23
Not applicableUnknownNCT05647590
What this trial is testing

SBRT/RT in Oligometastatic Stage IV NSCLC

Who this might be right for
Non Small Cell Lung Cancer
University Hospital Ostrava 10
Testing effectiveness (Phase 2)Looking for participantsNCT07099547
What this trial is testing

Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Testing effectiveness (Phase 2)Looking for participantsNCT04325425
What this trial is testing

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

Who this might be right for
Neuroendocrine Carcinoma
Centre Hospitalier Universitaire Dijon 218
Testing effectiveness (Phase 2)Active Not RecruitingNCT04745689
What this trial is testing

Study of AZD2811 + Durvalumab in ES-SCLC

Who this might be right for
Small-Cell Lung Cancer
AstraZeneca 31
Early research (Phase 1)Study completedNCT02300298
What this trial is testing

Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04956692
What this trial is testing

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

Who this might be right for
Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 531
Testing effectiveness (Phase 2)Study completedNCT04282109
What this trial is testing

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 141
Next Page